900.3500 -7.75 (-0.85%)
NSE Dec 31, 2025 15:51 PM
Volume: 151.3K
 

900.35
-0.85%
Geojit BNP Paribas
Strides reported its Q2FY22 revenue at Rs. 721cr, (4.8% QoQ, -9% YoY), enabled by a bounce back in the other regulated markets which was partially offset by an underperformance in the US markets. US markets (34% of total revenues) witnessed a 17% QoQ/-38% YoY...
Strides Pharma Science Ltd.'s price crossed above 50Day SMA today
More from Strides Pharma Science Ltd.
Recommended